François‐Xavier Danlos

Institut Gustave Roussy

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Aurélien Marabelle

Institut Gustave Roussy

117

Stéphane Champiat

Université Paris-Saclay

Jean‐Charles Soria

Institut Gustave Roussy

Laurence Zitvogel

Institut Gustave Roussy

Benjamin Besse

Institut Gustave Roussy

Capucine Baldini

Institut Gustave Roussy

Anne‐Gaëlle Goubet

Université Paris-Saclay

Christophe Massard

Institut Gustave Roussy

Nathalie Chaput

Institut Gustave Roussy

Jean‐Eudes Fahrner

Université Paris-Saclay

Cooperative Institutions

Inserm

477

Institut Gustave Roussy

374

Université Paris-Saclay

328

Assistance Publique – Hôpitaux de Paris

250

Centre National de la Recherche Scientifique

193

Université Paris Cité

191

Université Paris-Sud

136

Sorbonne Université

128

Sorbonne Paris Cité

La Ligue Contre le Cancer

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers

Cell Death and Disease (2024)

François‐Xavier Danlos Claudia Grajeda‐Iglesias Sylvère Durand Allan Sauvat Mathilde Roumier

2019-20 coronavirus outbreak

10.1038/s41419-024-06519-7

Cite

Citations (0)

Supplementary Figure S5 from Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma

François‐Xavier Danlos Matthieu Texier Bastien Job Séverine Mouraud Lydie Cassard

<p>Gating strategy for flow cytometry analyses of T cells infiltration on tumor biopsies.</p>

Infiltration (HVAC)

10.1158/2159-8290.22494717

Cite

Citations (0)

Supplementary Table S4 from Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma

François‐Xavier Danlos Matthieu Texier Bastien Job Séverine Mouraud Lydie Cassard

<p>Baseline characteristics of the patients treated according to their DCB status.</p>

Primary (astronomy)

10.1158/2159-8290.22494702.v1

Cite

Citations (0)

Table of Contents

CHEST Journal (2016)

Janna Landsperger Matthew W. Semler Li Wang Daniel W. Byrne Arthur Wheeler

Table (database)

10.1016/s0012-3692(16)47238-7

Cite

Citations (0)

Antibody drug conjugates in older patients: State of the art

Critical Reviews in Oncology/Hematology (2023)

Layal Rached Arthur Géraud Maxime Frélaut Zoé ap Thomas Vincent Goldschmidt

Geriatric oncology

10.1016/j.critrevonc.2023.104212

Cite

Citations (4)

Incidence of adverse events in older patients treated with Chemotherapy+Immunotherapy combinations

Journal of Geriatric Oncology (2023)

Layal Rached Ariane Laparra M. Aldea M. Frelaut Benjamin Besse

10.1016/s1879-4068(23)00350-8

Cite

Citations (0)

Impact of acetaminophen on the efficacy of immunotherapy in cancer patients

Annals of Oncology (2022)

Alban Bessede Aurélien Marabelle Jean‐Philippe Guégan François‐Xavier Danlos Sophie Cousin

Acetaminophen

Immune checkpoint

10.1016/j.annonc.2022.05.010

Cite

Citations (30)

Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors

Annals of Oncology (2022)

Florent Peyraud Jean‐Philippe Guégan D. Bodet Imane Nafia L. Fontan

10.1016/j.annonc.2022.07.001

Cite

Citations (38)

Table of Contents

Annals of Oncology (2022)

Philip Beer Andrew V. Biankin Ana Oaknin Tjalling Bosse Carien L. Creutzberg

Table (database)

10.1016/s0923-7534(22)03798-x

Cite

Citations (0)

Identification of Biomarkers Associated With the Combination of Immunotherapy and Anti-Angiogenic Drugs in the Treatment of Mesothelioma : Translational Analyses of the PEMBIB Clinical Trial Combining the Anti-PD1 Monoclonal Antibody Embrolizumab and the Anti-Angiogenic Tyrosine Kinase Inhibitor Nintedanib

HAL (Le Centre pour la Communication Scientifique Directe) (2021)

François‐Xavier Danlos

Identification

Source

Cite

Citations (0)